HELEN STALLINGS: Open Payments
NPI 1225635949 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 72 payments from 16 companies in 2025. Trend: 2023 $668 · 2024 $612 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $281 |
| Otsuka America Pharmaceutical, Inc. | 9 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $147 |
| Alkermes, Inc. | 4 | $89 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Lundbeck LLC | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $50 |
| Bausch Health US, LLC | 2 | $43 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $38 |
Products named: VRAYLAR, REXULTI, CAPLYTA, INGREZZA, Qelbree, APLENZIN, Jornay PM, Auvelity.
Industry payments across SC — which companies pay providers there.
